Update on Remdesivir, Investigational Antiviral for COVID-19
Update on Remdesivir, Investigational Antiviral for COVID-19
Chloroquine as a Treatment Agent for COVID-19: Hype or Hope?
Chloroquine as a Treatment Agent for COVID-19: Hype or Hope?
Real-World Pattern of Biologic Use in Patients with Inflammatory Bowel Disease
Real-World Pattern of Biologic Use in Patients with Inflammatory Bowel Disease
Bottles of Lies: The Inside Story of the Generic Drug Boom
Bottles of Lies: The Inside Story of the Generic Drug Boom
Delirium: The Hidden Disorder Plaguing ICU Patients
Delirium: The Hidden Disorder Plaguing ICU Patients
Facts, Myths, & Misconceptions of Medical Marijuana
Facts, Myths, & Misconceptions of Medical Marijuana
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
